Robert Hershberg Fate Therapeutics Inc (FATE) insider trading activity

Robert Hershberg is Director of FATE THERAPEUTICS INC. Currently has a direct ownership of 10,659 shares of FATE, which is worth approximately $25,794. The most recent transaction as insider was on Jun 09, 2022, when has been sold 8,650 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.7K

0% 3M change

0% 12M change

Total Value Held $25,794

ROBERT HERSHBERG Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 09 2022	BUY Grant, award, or other acquisition	-	8,650 Added 44.8%	10,659 Common Stock
Jun 03 2022	SELL Open market or private sale	$15,288 $22.75 p/Share	672 Reduced 25.07%	2,009 Common Stock
Jun 02 2021	BUY Grant, award, or other acquisition	-	2,681 Added 50.0%	2,681 Common Stock

Also insider at

ADPT

Adaptive Biotechnologies Corp Healthcare

Director

NSTG

NanoString Technologies Inc Healthcare

Director

SBTX

Silverback Therapeutics, Inc. Healthcare

Director

RXRX

RECURSION PHARMACEUTICALS, INC. Healthcare

Director

HLVX

HilleVax, Inc. Healthcare